L1000FWD
Large Scale Visualization of Drug
Induced Transcriptomic Signatures
Map
All cell lines
BT20 (kNN)
THP1 (tSNE)
NPC (tSNE)
HT29 (tSNE)
A549 (kNN)
A375 (kNN)
A375 (tSNE)
HCC515 (tSNE)
MDAMB231 (kNN)
HEPG2 (tSNE)
HCC515 (kNN)
MDAMB231 (tSNE)
NEU (tSNE)
SKB (tSNE)
A549 (tSNE)
SKBR3 (kNN)
HA1E (kNN)
MCF10A (tSNE)
ASC (kNN)
VCAP (kNN)
HT29 (kNN)
BT20 (tSNE)
VCAP (tSNE)
MCF7 (kNN)
THP1 (kNN)
ASC (tSNE)
MCF10A (kNN)
NEU (kNN)
PC3 (tSNE)
HA1E (tSNE)
SKB (kNN)
NPC (kNN)
SKBR3 (tSNE)
MCF7 (tSNE)
HS578T (tSNE)
PHH (tSNE)
PHH (kNN)
PC3 (kNN)
HS578T (kNN)
HEPG2 (kNN)
Drugs
Signatures
Download
API
Signature Report
Signature ID
CPC001_PC3_24H:BRD-K74305673-001-01-3:10
Cell Line
PC3
Dose
10.0 μM
Time
24 hours
p-value
< 0.0001
Drug Name
IKK-2-inhibitor-V
External Links and Downloads
Up (209)
Down (256)
Combined (465)
Gene lists
Submit for Analysis with Enrichr
IKK-2-INHIBITOR-V (BRD-K74305673)
Overview
pert_id
BRD-K74305673
Name
IKK-2-inhibitor-V
Collection
BIOA
MOA
IKK inhibitor, NFkB pathway inhibitor
Target(s)
IKBKB
Indication(s)
Unknown
Phase
Phase 1
Canonical SMILES
Oc1ccc(Cl)cc1C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F
InChI key
InChIKey=CHILCFMQWMQVAL-UHFFFAOYSA-N
InChI string
InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25)
Molecular formula
C15H8ClF6NO2
Molecular weight
383.673
External links
PubChem
5081913
Wikipedia
http://www.emdmillipore.com/life-science-research/ikk-2-inhibitor-v/EMD_BIO-401482/p_6Cub.s1LUxkAAAEWxWEfVhTm?PortalCatalogID=merck4biosciences&CountryName=United+States+of+America
SEP-L1000
BRD-K74305673
Predicted MOAs
MOA
Probability
EGFR inhibitor
0.1871
cyclooxygenase inhibitor
0.1481
MEK inhibitor
0.1094
RAF inhibitor
0.0969
topoisomerase inhibitor
0.0381
CDK inhibitor
0.0380
HDAC inhibitor
0.0360
retinoid receptor agonist
0.0344
PARP inhibitor
0.0310
PLK inhibitor
0.0299
Chemical structure